Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment
Clinical trial NCT06662877 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06662877
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2029-09-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.